Sign up to save your podcasts
Or
Share A Cutting-Edge Cancer Treatment Is Under FDA Investigation—for Cancer Risk
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
A Cutting-Edge Cancer Treatment Is Under FDA Investigation—for Cancer Risk
CAR-T cell therapy harnesses the immune system to attack blood cancers. Six years after approving the first treatment, the FDA is investigating whether it can give rise to secondary cancers.
Read this story here.
Learn about your ad choices: dovetail.prx.org/ad-choices
View all episodes
By WIRED
4.3
5656 ratings
CAR-T cell therapy harnesses the immune system to attack blood cancers. Six years after approving the first treatment, the FDA is investigating whether it can give rise to secondary cancers.
Read this story here.
Learn about your ad choices: dovetail.prx.org/ad-choices
More shows like Science, Spoken
View all
The Political Scene | The New Yorker
4,008 Listeners
Making Sense with Sam Harris
26,388 Listeners
Pivot
9,490 Listeners
Uncanny Valley | WIRED
482 Listeners
What's New
100 Listeners
Business, Spoken
50 Listeners
Pod Save America
87,159 Listeners
The Daily
112,433 Listeners
Security, Spoken
60 Listeners
Ologies with Alie Ward
24,235 Listeners
Citadel Dropouts: a Game of Thrones Podcast
77 Listeners
Hard Fork
5,475 Listeners
Spark & Fire: Fuel Your Creativity
398 Listeners
Huberman Lab
29,130 Listeners
The Ezra Klein Show
16,083 Listeners
Unexplainable
2,278 Listeners
On with Kara Swisher
3,423 Listeners